Suppr超能文献

薏苡仁精液通过阻断 PI3K-AKT-mTOR 通路增强 PD-1 抑制剂对 A549 细胞系的抗肿瘤作用的潜力。

Potential of semen coicis in enhancing the anti-tumor effects of PD-1 inhibitor on A549 cell lines by blocking the PI3K-AKT-mTOR pathway.

机构信息

The First Clinical Medical School, Guangzhou University of Chinese Medicine, Guangzhou, 510000, China.

Department of Pulmonary and Critical Care Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, 510000, China.

出版信息

Clin Transl Oncol. 2024 Sep;26(9):2250-2261. doi: 10.1007/s12094-024-03444-1. Epub 2024 Mar 30.

Abstract

BACKGROUND

The objective of this research was to investigate how the combination of semen coicis extract and PD-1 inhibitors can potentially work together to enhance the anti-tumor effects, with a focus on understanding the underlying mechanism.

METHODS

We obtained the active components and specific targets of semen coicis in the treatment of NSCLC from various databases, namely TCMSP, GeneCard, and OMIM. By utilizing the STRING database and Cytoscape software, we established a protein interaction network (PPI) for the active ingredient of semen coicis and the target genes related to NSCLC. To explore the potential pathways involved, we conducted gene ontology (GO) and biological pathway (KEGG) enrichment analyses, which were further supported by molecular docking technology. Additionally, we conducted cyto-inhibition experiments to verify the inhibitory effects of semen coicis alone or in combination with a PD-1 inhibitor on A549 cells, along with examining the associated pathways. Furthermore, we investigated the synergistic mechanism of these two drugs through cytokine release experiments and the PD-L1 expression study on A549 cells.

RESULTS

Semen coicis contains two main active components, Omaine and (S)-4-Nonanolide. Its primary targets include PIK3R1, PIK3CD, PIK3CA, AKT2, and mTOR. Molecular docking experiments confirmed that these ingredients and targets form stable bonds. In vitro experiments showed that semen coicis demonstrates inhibitory effects against A549 cells, and this effect was further enhanced when combined with PD-1 inhibitors. PCR and WB analysis confirmed that the inhibition of the PI3K-AKT-mTOR pathway may contribute to this effect. Additionally, semen coicis was observed to decrease the levels of IFN-γ, IL-6, and TNF-α, promoting the recovery of the human anti-tumor immune response. And semen coicis could inhibit the induced expression of PD‑L1 of A549 cells stimulated by IFN‑γ as well.

CONCLUSION

Semen coicis not only has the ability to kill tumor cells directly but also alleviates the immunosuppression found in the tumor microenvironment. Additionally, it collaboratively enhances the effectiveness of PD-1 inhibitors against tumors by blocking the activation of PI3K-AKT-mTOR.

摘要

背景

本研究旨在探讨薏苡仁提取物与 PD-1 抑制剂联合应用如何增强抗肿瘤作用,并深入研究其作用机制。

方法

我们从 TCMSP、GeneCard 和 OMIM 等多个数据库中获取薏苡仁治疗 NSCLC 的活性成分和特定靶点。利用 STRING 数据库和 Cytoscape 软件构建薏苡仁活性成分与 NSCLC 相关靶基因的蛋白质相互作用网络(PPI)。通过基因本体(GO)和生物通路(KEGG)富集分析探讨潜在通路,并进一步通过分子对接技术进行验证。此外,我们进行了细胞抑制实验,以验证薏苡仁单独或与 PD-1 抑制剂联合对 A549 细胞的抑制作用,并研究相关通路。进一步通过细胞因子释放实验和 A549 细胞 PD-L1 表达研究探讨这两种药物的协同作用机制。

结果

薏苡仁含有两种主要活性成分,即奥马宁和(S)-4-壬醇。其主要靶点包括 PIK3R1、PIK3CD、PIK3CA、AKT2 和 mTOR。分子对接实验证实这些成分和靶点形成稳定的结合。体外实验表明,薏苡仁对 A549 细胞具有抑制作用,与 PD-1 抑制剂联合使用时效果进一步增强。PCR 和 WB 分析证实抑制 PI3K-AKT-mTOR 通路可能是其作用机制之一。此外,薏苡仁还可降低 IFN-γ、IL-6 和 TNF-α的水平,促进人体抗肿瘤免疫反应的恢复。并且薏苡仁可以抑制 IFN-γ诱导的 A549 细胞 PD-L1 的表达。

结论

薏苡仁不仅具有直接杀伤肿瘤细胞的能力,还能减轻肿瘤微环境中的免疫抑制作用。此外,它通过阻断 PI3K-AKT-mTOR 的激活,与 PD-1 抑制剂协同增强对肿瘤的治疗效果。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验